The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expression

被引:63
作者
Radtke, S
Haan, S
Jörissen, A
Hermanns, HM
Diefenbach, S
Smyczek, T
Schmitz-VandeLeur, H
Heinrich, PC
Behrmann, I
Haan, C
机构
[1] Uniklin Aachen, Inst Biochem, D-52074 Aachen, Germany
[2] Univ Luxembourg, Fac Sci Technol & Commun, Lab Biol & Physiol Integree, L-1511 Luxembourg, Luxembourg
关键词
D O I
10.1074/jbc.M500822200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The presence of a Src homology 2 ( SH2) domain sequence similarity in the sequence of Janus kinases ( Jaks) has been discussed since the first descriptions of these enzymes. We performed an in depth study to determine the function of the Jak1 SH2 domain. We investigated the functionality of the Jak1 SH2 domain by stably reconstituting Jak1- defective human fibrosarcoma cells U4C with endogenous amounts of Jak1 in which the crucial arginine residue Arg(466) within the SH2 domain has been replaced by lysine. This mutant still binds to the receptor subunits gp130 and OSMR. Moreover, the SH2 R466K mutation does not affect the subcellular distribution of Jak1 as assessed by cell fractionation and confocal microscopy of cells expressing endogenous levels of non- tagged or a yellow fluorescent protein ( YFP)- tagged Jak1- R466K, respectively. Likewise, the signaling capacity of Jak1 was not affected by this point mutation. However, we found that the SH2 domain is structurally important for cytokine receptor binding and surface expression of the OSMR.
引用
收藏
页码:25760 / 25768
页数:9
相关论文
共 38 条
[31]   Regulation of the Jak2 tyrosine kinase by its pseudokinase domain [J].
Saharinen, P ;
Takaluoma, K ;
Silvennoinen, O .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (10) :3387-3395
[32]   Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells [J].
Sakaguchi, K ;
Okabayashi, Y ;
Kido, Y ;
Kimura, S ;
Matsumura, Y ;
Inushima, K ;
Kasuga, M .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (04) :536-543
[33]   Different protein turnover of interleukin-6-type cytokine signalling components [J].
Siewert, E ;
Müller-Esterl, W ;
Starr, R ;
Heinrich, PC ;
Schaper, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 265 (01) :251-257
[34]  
Stoica B, 1998, J IMMUNOL, V160, P1059
[35]   SOLUBLE HUMAN INTERLEUKIN-6 RECEPTOR - EXPRESSION IN INSECT CELLS, PURIFICATION AND CHARACTERIZATION [J].
WEIERGRABER, O ;
HEMMANN, U ;
KUSTER, A ;
MULLERNEWEN, G ;
SCHNEIDER, J ;
ROSEJOHN, S ;
KURSCHAT, P ;
BRAKENHOFF, JPJ ;
HART, MHL ;
STABEL, S ;
HEINRICH, PC .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 234 (02) :661-669
[36]   2 NOVEL PROTEIN-TYROSINE KINASES, EACH WITH A 2ND PHOSPHOTRANSFERASE-RELATED CATALYTIC DOMAIN, DEFINE A NEW CLASS OF PROTEIN-KINASE [J].
WILKS, AF ;
HARPUR, AG ;
KURBAN, RR ;
RALPH, SJ ;
ZURCHER, G ;
ZIEMIECKI, A .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (04) :2057-2065
[37]   SOLUTION STRUCTURE OF THE HUMAN PP60(C-SRC) SH2 DOMAIN COMPLEXED WITH A PHOSPHORYLATED TYROSINE PENTAPEPTIDE [J].
XU, RX ;
WORD, JM ;
DAVIS, DG ;
RINK, MJ ;
WILLARD, DH ;
GAMPE, RT .
BIOCHEMISTRY, 1995, 34 (07) :2107-2121
[38]   A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-α signaling [J].
Yeh, TC ;
Dondi, E ;
Uzé, G ;
Pellegrini, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :8991-8996